Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HUBB | GH |
|---|---|---|
| Price | $459.02 | $178.43 |
| Change today | ▲ 1.19% | ▲ 0.04% |
| Market cap | $24.24B | $23.94B |
| Return, 3 months | -6.1% | +4.5% |
| Return, year to date | +4.3% | +74.7% |
| Return, 1 year | +7.9% | +184.8% |
| P/E (TTM) | 27.2 | -50.8 |
| P/B | 6.2 | -107.4 |
| P/E percentile vs own 5y | 44th | 0th |
| Dividend yield | 1.22% | – |
| Revenue growth (YoY, latest qtr) | +15.3% | +44.3% |
| Net profit growth (YoY) | -1.3% | -20.3% |
| Gross margin | 35.2% | 65.0% |
| Operating margin | 20.2% | -39.7% |
| Net margin | 14.5% | -38.3% |
| Return on equity | 24.3% | – |
| Analyst target vs. price | +22.9% | +12.9% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 45 | 61 |
| 30-day volatility | 23.4% | 40.6% |
| Max drawdown, 1 year | -20.9% | -33.0% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
